1. A Pilot Trial of Unmatched Human Placental Derived Stem Cells (HPDSCs) in Conjunction with Unrelated Cord Blood Transplantation (UCBT) in Children and Young Adults with Malignant and Non-Malignant Disease (IND 14949) 
Michelle Nash, MD, Lauren Harrison, RN, MSN, Michael A. Pulsipher, MD, Qiuhu Shi, PhD, Debra Abrams, MGC, CGC, MLIS, Roger Giller, MD, Berkley Nickerson, RN, MSN, CFNP, Erin Morris, RN, BSN, Olga Militano, PharmD, Janet Ayello, MS, MT(ASCP), Mildred Semidei-Pomales, MS, Sandra Fabricatore, RN, MSN, CPNP, Xiaokui Zhang, PhD, Jodi Gurney, Stacy Herb, Rajarajeswari Sivalenka, PhD, Carmella van de Ven, MS, Nader El-Mallawany, MD, Cori Abikoff, MD, Jessica Hochberg, MD, Lee-Ann Baxter Lowe, PhD, Mitchell S. Cairo, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S143-S144 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 Overall explermental plan
MAC: Myeloablative Conditioning: TBI 1200cGy; Ciofarabine 52 mg/m2 ×5 days: Ara-C1 gm/m2/d × 6 days
RTC: Reduced Toxicity Conditioning: Busulfan 4 mg/kg/d × 4 days; Fludarabine 30 mg/m2/d × 5 days; Alemtuzumb 2 mg/m2 × 1 days, 6 mg/m2 × 2 days, and 20 mg/m2 × 2 days
Biology of Blood and Marrow Transplantation  , S143-S144DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2 Probability of Grade II-IV AGVHD
Biology of Blood and Marrow Transplantation  , S143-S144DOI: ( /j.bbmt )
Copyright © Terms and Conditions